SCHEMBL20182358

SCHEMBL20182358

Cc1ccccc1C1=NOC(C(C)Cl)C1

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
NPC1 O15118 4/20 0.35
RAB9A P51151 4/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
ALDH1A1 P00352 2/20 0.35
MAPT P10636 2/20 0.35
HPGD P15428 2/20 0.35
LMNA P02545 1/20 0.35
CA12 O43570 1/20 0.35
CASP3 P42574 1/20 0.35
SENP8 Q96LD8 1/20 0.35
SENP7 Q9BQF6 1/20 0.35
SENP6 Q9GZR1 1/20 0.35
POLB P06746 1/20 0.35
KIF11 P52732 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21066142 0.74 CA1 (0.51) CA1CA2NPC1RAB9ASMN1; SMN2
SCHEMBL21066144 0.69 CA1 (0.40) CA1CA2NPC1RAB9ASMN1; SMN2
SCHEMBL21066129 0.68 KDM4E (0.36) ALDH1A1MAPTHPGDPOLB
SCHEMBL21066088 0.66 CA1 (0.46) CA1CA2
SCHEMBL21066130 0.63 HTR2A (0.39) CA1CA2NPC1RAB9ASMN1; SMN2
SCHEMBL21066128 0.63 MEN1 (0.38) CA1CA2NPC1RAB9ASMN1; SMN2
SCHEMBL21066085 0.62 LMNA (0.45) NPC1RAB9ASMN1; SMN2ALDH1A1MAPT
SCHEMBL21066133 0.61 CA12 (0.41) NPC1RAB9ASMN1; SMN2ALDH1A1MAPT
SCHEMBL21066090 0.61 MAOB (0.48) NPC1RAB9ASMN1; SMN2ALDH1A1MAPT
SCHEMBL21066127 0.60 NPC1 (0.49) CA1CA2NPC1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018094137-A1 PYRROLOPYRIMIDINES AS CFTR POTENTIATORS CYSTIC FIBROSIS FOUNDATION THERAPEUTICS INC. (US) 2018-05-24 WO disclosed